(NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Nnamdi Njoku has been appointed ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that ...

Healthcare tech company Omnicell (NASDAQ:OMCL) announced in Q2 CY2025, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s revenue guidance ($295 million at the midpoint) ...

Expands pharmacy supply chain capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy, ...

Analysts' ratings for Omnicell (NASDAQ:OMCL) over the last quarter vary from bullish to bearish, as provided by 5 analysts. In the table below, you'll find a summary of their recent ratings, revealing ...

Hello, and welcome to the Omnicell Fiscal Year and Fourth Quarter 2025 Results. [Operator Instructions] And please note that this call is being recorded. I will now turn the call over to Kathleen ...

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday before market hours. Here’s what investors should know. Omnicell beat analysts’ revenue expectations by ...

Omnicell, the medication and supply management firm, has completed its acquisition of St. Petersburg, Fla.-based MTS Medication Technologies, which develops medication adherence packaging systems.

Thank you for standing by. At this time, I would like to welcome everyone to today's Omnicell Third Quarter 2025 Financial Results Call. [Operator Instructions] After the speaker's remarks, there will ...